Abstract:Angiogenesis contributes fundamentally to embryonic development, tissue homeostasis, and wound healing. Basic fibroblast growth factor (FGF2) is recognized as the first proangiogenic molecule discovered, and it facilitates angiogenesis by activating FGF receptor 1 (FGFR1) signaling in endothelial cells. However, the precise roles of FGFR and the FGF/FGFR signaling axis in angiogenesis remain unclear, especially because of the contradictory phenotypes of in vivo FGF and FGFR gene deficiency models. Our previous study results suggested a potential role of posttranslational small ubiquitin-like modifier modification (SUMOylation), with highly dynamic regulatory features, in vascular development and disorder. Here, we identified SENP1-regulated endothelial FGFR1 SUMOylation at conserved lysines responding to proangiogenic stimuli, while SENP1 functioned as the deSUMOylase. Hypoxia-enhanced FGFR1 SUMOylation restricted the tyrosine kinase activation of FGFR1 by modulating the dimerization of FGFR1 and FGFR1 binding with its phosphatase PTPRG. Consequently, it facilitated the recruitment of FRS2α to VEGFR2 but limited additional recruitment of FRS2α to FGFR1, supporting the activation of VEGFA/VEGFR2 signaling in endothelial cells. Furthermore, SUMOylation-defective mutation of FGFR1 resulted in exaggerated FGF2/FGFR1 signaling but suppressed VEGFA/VEGFR2 signaling and the angiogenic capabilities of endothelial cells, which were rescued by FRS2α overexpression. Reduced angiogenesis and endothelial sprouting in mice bearing an endothelial-specific, FGFR1 SUMOylation-defective mutant confirmed the functional significance of endothelial FGFR1 SUMOylation in vivo. Our findings identify the reversible SUMOylation of FGFR1 as an intrinsic fine-tuned mechanism in coordinating endothelial angiogenic signaling during neovascularization; SENP1-regulated FGFR1 SUMOylation and deSUMOylation controls the competitive recruitment of FRS2α by FGFR1 and VEGFR2 to switch receptor-complex formation responding to hypoxia and normoxia angiogenic environments.

Nek2A Phosphorylates and Stabilizes SuFu: A New Strategy of Gli2/Hedgehog Signaling Regulatory Mechanism.

Nek2a/Sufu Feedback Loop Regulates Gli-Mediated Hedgehog Signaling Pathway

Differential regulation of Gli proteins by Sufu in the lung affects PDGF signaling and myofibroblast development.

Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma.

Negative regulation of Gli1 and Gli2 activator function by Suppressor of fused through multiple mechanisms

MEKK2 and MEKK3 Suppress Hedgehog Pathway-Dependent Medulloblastoma by Inhibiting GLI1 Function

Positive feedback of SuFu negating protein 1 on Hedgehog signaling promotes colorectal tumor growth

Genomic dimensions of Su(H)-targeted regulatory belts in Drosophila

Hedgehog signaling pathway member SuFu in colorectal cancer

Inhibition of the Transcription Factor ZNF281 by SUFU to Suppress Tumor Cell Migration

Interacting Proteins of Tumor Suppressor SuFu by Yeast Two Hybrid

Structural Insight into the Mutual Recognition and Regulation Between Suppressor of Fused and Gli/Ci.

Cilium-independent Regulation of Gli Protein Function by Sufu in Hedgehog Signaling is Evolutionarily Conserved.

FGFR1 SUMOylation Coordinates Endothelial Angiogenic Signaling in Angiogenesis

Antagonistic and Cooperative Actions of Kif7 and Sufu Define Graded Intracellular Gli Activities in Hedgehog Signaling.

SCF (Fbxl17) ubiquitylation of Sufu regulates Hedgehog signaling and medulloblastoma development

Structural Insight into the Recognition Between Sufu and Fused in the Hedgehog Signal Transduction Pathway.

Molecular mechanisms of suppressor of fused in regulating the hedgehog signalling pathway (Review)

POMP Interacts with Suppressor of Fused in Regulating Hedgehog Signaling

Members of the Rusc Protein Family Interact with Sufu and Inhibit Vertebrate Hedgehog Signaling.

Dual function of suppressor of fused in Hh pathway activation and mouse spinal cord patterning.